新村 浩明 しんむら ひろあき 先生

来歴等

略歴

1993年 富山医科薬科大学（現富山大学）医学部 卒業
1993年 東京女子医科大学泌尿器科 入局
2005年 東京女子医科大学大学院 修了
2005年 東京女子医科大学泌尿器科 助手
2005年 財団法人ときわ会　いわき泌尿器科
2011年 公益財団法人ときわ会　常磐（じょうばん）病院
2015年 公益財団法人ときわ会　常磐（じょうばん）病院 院長

論文

• A Comparative Survival Analysis Between Evacuees and Nonevacuees Among Dialysis Patients in Fukushima Prefecture After Japan's 2011 Fukushima Nuclear Incident. Disaster Med Public Health Prep. 2019 May 27:1-7.

  Nomura S, Matsuzaki Y, Sato Y, Takasaki J, Sonoda Y, Shimmura H, Kodama Y

• Modified Clown Therapy using Traditional Japanese-style costumes for Elderly Patients in Post-disaster Fukushima. QJM. 2019 Feb 18.

  Kanemoto Y, Tanimoto T, Shimmura H

• Painless vascular leiomyoma found after incision of the vaginal wall: A case report. Urol Case Rep. 2017 Dec 16;17:19-21.

  Yamashita K, Shimmura H, Tokiwa S, Kato S

• Carfilzomib for relapsed or refractory multiple myeloma. Lancet Oncol. 2018 Jan;19(1)

  Tanimoto T, Tsuda K, Oshima K, Mori J, Shimmura H

• Degarelix treatment is compatible with diabetes and antithrombotic therapy in patients with prostate cancer. Res Rep Urol. 2017 Dec 6;9:225-232.

  okiwa S, Shimmura H, Nomura S, Watanabe R, Kurita M, Yoshida N, Yamashita K, Nishikawa Y, Kouzmenko A, Kato S

• Rituximab and autologous stem-cell transplantation for high-risk diffuse large B-cell lymphoma. Lancet Oncol. 2017 Oct;18(10):e557.

  Tanimoto T, Oshima K, Tsuda K, Mori J, Shimmura H

• Essential medicines for universal health coverage. Lancet. 2017 May 13;389(10082):1880-1881.

  Tanimoto T, Tsuda K, Kurokawa T, Mori J, Shimmura H

• Intensive blood pressure lowering. Lancet. 2016 Jun 4;387(10035):2291.

  Sonoda Y, Higuchi A, Morita T, Mori J, Shimmura H

• Whole body counter assessment of internal radiocontamination in patients with end-stage renal disease living in areas affected by the Fukushima Daiichi nuclear power plant disaster: a retrospective observational study. BMJ Open. 2015 Dec 7;5(12):e009745.

  Shimmura H, Tsubokura M, Kato S, Akiyama J, Nomura S, Mori J, Tanimoto T, Abe K, Sakai S, Kawaguchi H, Tokiwa M

• Minimal Internal Radiation Exposure in Residents Living South of the Fukushima Daiichi Nuclear Power Plant Disaster. PLoS One. 2015 Oct 20;10(10):e0140482.

  Akiyama J, Kato S, Tsubokura M, Mori J, Tanimoto T, Abe K, Sakai S, Hayano R, Tokiwa M, Shimmura H

• Whole-body counter surveys of over 2700 babies and small children in and around Fukushima Prefecture 33 to 49 months after the Fukushima Daiichi NPP accident. Proc Jpn Acad Ser B Phys Biol Sci. 2015;91(8):440-6.

  Hayano RS, Tsubokura M, Miyazaki M, Ozaki A, Shimada Y, Kambe T, Nemoto T, Oikawa T, Kanazawa Y, Nihei M, Sakuma Y, Shimmura H, Akiyama J, Tokiwa M

• Impact of the Great Eastern Japan Earthquake on transplant renal function in Iwaki city, Fukushima. Transplant Proc. 2014;46(2):613-5.

  Shimmura H, Kawaguchi H, Tokiwa M, Tanabe K

• Complete remission of lung metastasis following adoptive immunotherapy using activated autologous gammadelta T-cells in a patient with renal cell carcinoma. Anticancer Res. 2010 Feb;30(2):575-9.

  Kobayashi H, Tanaka Y, Shimmura H, Minato N, Tanabe K

• Combination effect of mycophenolate mofetil with mizoribine on cell proliferation assays and in a mouse heart transplantation model. Transplantation. 2006 Jul 27;82(2):175-9.

  Shimmura H, Tanabe K, Habiro K, Abe R, Toma H

• Long-term results of living kidney transplantation from HLA-identical sibling donors under calcineurin inhibitor immunosuppression. Int J Urol. 2006 May;13(5):502-8.

  Shimmura H, Tanabe K, Ishida H, Miyamoto N, Tokumoto T, Ishikawa N, Toma H

• Lack of correlation between results of ABO-incompatible living kidney transplantation and anti-ABO blood type antibody titers under our current immunosuppression. Transplantation. 2005 Oct 15;80(7):985-8.

  Shimmura H, Tanabe K, Ishida H, Tokumoto T, Ishikawa N, Miyamoto N, Shirakawa H, Setoguchi K, Nakajima I, Fuchinoue S, Teraoka S, Toma H

• Effect of inflammation on costimulation blockade-resistant allograft rejection. Am J Transplant. 2005 Apr;5(4 Pt 1):702-11.

  Habiro K, Shimmura H, Kobayashi S, Kotani M, Ishida Y, Tanabe K, Toma H, Abe R

• Impact of positive PRA on the results of ABO-incompatible kidney transplantation. Transplant Proc. 2004 Sep;36(7):2169-71.

  Shimmura H, Tanabe K, Tokumoto T, Ishida H, Ishikawa N, Miyamoto N, Shimizu T, Shirakawa H, Setoguchi K, Toma H

• Impact of HLA-identity on results of ABO-incompatible living kidney transplantation. Transplant Proc. 2004 Sep;36(7):2172-4.

  Shimmura H, Tanabe K, Tokumoto T, Ishida H, Ishikawa N, Miyamoto N, Shimizu T, Shirakawa H, Setoguchi K, Teraoka S, Toma H

• Analysis of cause of death with a functioning graft: a single-center experience. Transplant Proc. 2004 Sep;36(7):2026-9

  Shimmura H, Tanabe K, Tokumoto T, Ishida H, Ishikawa N, Miyamoto N, Shimizu T, Shirakawa H, Setoguchi K, Teraoka S, Toma H

• Time-dependent risk factors influencing the long-term outcome in living renal allografts: donor age is a crucial risk factor for long-term graft survival more than 5 years after transplantation. Transplantation. 2001 Sep 15;72(5):940-7.

  Toma H, Tanabe K, Tokumoto T, Shimizu T, Shimmura H

• Discontinuation of immunosuppressive antimetabolite for parvovirus B19-associated anemia in kidney transplant patients. Transplant Proc. 2000 Nov;32(7):1967-70.

  Shimmura H, Tanabe K, Ishikawa N, Tokumoto T, Toda F, Toma H

• Effect of donor age and rejection episodes on hypophosphatemia in long-term kidney transplant patients. Transplant Proc. 2000 Nov;32(7):1905-6.

  Shimmura H, Tanabe K, Ishikawa N, Tokumoto T, Toda F, Toma H

• Conversion of renal transplant immunosuppression from tacrolimus (FK 506) to cyclosporine: a single center experience. Transplant Proc. 2000 Nov;32(7):1733-5.

  Ichikura H, Tanabe K, Tokumoto T, Shimuzu T, Ishikawa N, Harano M, Inui M, Manu M, Ito S, Shimmura H, Okuda H, Yagisawa T, Fuchinoue S, Toma H

• Removal of anti-A/B antibodies with plasmapheresis in ABO-incompatible kidney transplantation. Ther Apher. 2000 Oct;4(5):395-8.

  Shimmura H, Tanabe K, Ishikawa N, Tokumoto T, Fuchinoue S, Takahashi K, Toma H, Agishi T

• Role of anti-A/B antibody titers in results of ABO-incompatible kidney transplantation. Transplantation. 2000 Nov 15;70(9):1331-5.

  Shimmura H, Tanabe K, Ishikawa N, Tokumoto T, Takahashi K, Toma H

• Influence of donor renal reserve on the long-term results of living kidney transplantation from elderly donors. Transplant Proc. 1999 Nov;31(7):2874-6.

  Shimmura H, Tanabe K, Ishikawa N, Kanematsu A, Tokumoto T, Oshima T, Fuchinoue S, Toma H

• Angiographic embolization in patients with renal allograft arteriovenous fistula. Transplant Proc. 1998 Nov;30(7):2990-2.

  Shimmura H, Ishikawa N, Tanabe K, Tokumoto T, Ohsima T, Fuchinoue S, Ota K, Toma H

著書

• 「医療・介護産業」のタブーに斬りこむ! 日本国・不安の研究 猪瀬直樹著　PHP研究所　2019年

SNS・ブログ等

• Twitter
  • 新村浩明先生のTwitter
• Facebook
  • 新村浩明先生のFacebook
• その他メディア
  • 新村浩明先生のインスタグラム
  • 公益財団法人 ときわ会 常磐病院のYouTubeチャンネル